Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

NCT00867113 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumor (GIST)

Interventions

DRUG: imatinib mesylate

Sponsor

Novartis Pharmaceuticals